Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing torcetrapib/atorvastatin versus ezetimibe/simvastatin in people with a cholesterol disorder was terminated, according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• Torcetrapib/atorvastatin (torcetrapib; atorvastatin)
• ezetimibe/simvastatin (ezetimibe/simvastatin)

Snippet

Sponsor: Pfizer | Conditions: Hyperlipidemia, Dyslipidemia | Phase 3 | Status: TERMINATED